Claire Gomm

Hounslow Community Safety Partnership Board Member

Hounslow Community Safety Partnership Board - Thursday, 30 April 2026 3:00 pm

Hounslow Community Safety Partnership Board Member

Hounslow Community Safety Partnership Board - Thursday, 29 January 2026 - 9:30 am

The Hounslow Community Safety Partnership Board met on Thursday, 29 January 2026, to discuss crime performance, the London Fire Brigade's contribution to community safety, and updates on information sharing protocols and counter-terrorism efforts. Key discussions included a detailed overview of crime trends, with violence against the person remaining the highest offence category, and a significant increase in drug offences. The board also reviewed the London Fire Brigade's strategies for risk reduction and partnership working.

Hounslow Community Safety Partnership Board Member

Hounslow Community Safety Partnership Board - Thursday, 23 October 2025 3:00 pm

The Hounslow Community Safety Partnership Board convened to discuss crime trends, drug strategy achievements, and community safety initiatives. The board reviewed the Safer Communities Dashboard, highlighting crime levels and public perception, and discussed the progress and future priorities of the Hounslow Drug and Alcohol Partnership Board. Members also acknowledged the successes of the White Ribbon Action Plan and agreed to proposed initiatives for its third year.

Hounslow Health and Wellbeing Board Member

Hounslow Health and Wellbeing Board - Wednesday, 15 October 2025 4:00 pm

The Hounslow Health and Wellbeing Board met to discuss a range of topics, including updates on domiciliary care, extra care housing, and a hospital discharge pilot. The board was also scheduled to discuss the Better Care Fund, the Health and Wellbeing Strategy Progress Report, and the Joint Strategic Needs Assessment.

Hounslow Health and Wellbeing Board Officer

Special, Hounslow Health and Wellbeing Board - Tuesday, 2 September 2025 6:15 pm

The Hounslow Health and Wellbeing Board met to discuss the approval and publication of the Pharmaceutical Needs Assessment 2025. The board was also scheduled to note the Monitoring Officer's guidance on declaring interests.